FDA cuts, zombie biotechs, and too much weight loss?
On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight loss, and zombie biotech firms.
How will cuts to Food and Drug Administration staff affect the drug industry? Are companies pushing for too much weight loss from new drugs? And what will bring biotech out of its doldrums?
We discuss all that and more on the latest episode of “The Readout LOUD.” Mizuho analyst Jared Holz joins to discuss Adam’s column on biotech’s dark period. We also talk about Elaine’s latest article on the push for greater and greater weight loss from obesity drugs, along with developments at Solid Biosciences and federal job cuts.
